OnKure Therapeutics, Inc.
OKUR • XNAS
OnKure Therapeutics, Inc. is a pharmaceutical preparations company trading on XNAS, led by CEO Nicholas A. Saccomano, with a market cap of $66.7M.
Market Cap$66.7M
CEONicholas A. Saccomano
CountryUnited States of America
PHARMACEUTICAL PREPARATIONS
Next EarningsMay 5, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
OKU
OnKure Therapeutics, Inc. FAQ
Common questions about OnKure Therapeutics, Inc.
OnKure Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 5, 2026 before market open. Analysts estimate revenue of $166.7K.